Ansuvimab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ansuvimab. Educational only — not medical advice.
Labeled uses
EBANGA is indicated for the treatment of infection caused by Orthoebolavirus zairense (formerly Zaire ebolavirus) in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection [see Dosage and Administration (2.2) and Clinical Studies (14) ].
Source: FDA labeling via NIH DailyMed (set de220c8f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.